Exascale Labs Holdings Inc. cash flow statement XLABW

Annual Quarterly

In fiscal 2026, which ended Jun 30, 2026, Exascale Labs Holdings Inc. used $2.8 million of cash from operations.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 30, 2026
Operating
Depreciation and amortization
0
Stock-based compensation
0
Operating cash flow
-3
Investing
Investing cash flow
1
Financing
Financing cash flow
-0
Ratios
Stock-based compensation to revenue
0.00%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Services-Prepackaged Software (SIC 7372)
Listed as
XLAB (Nasdaq), XLABW (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Houston, TX
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
2109869
Former names
D. Boral ARC Merger Corp (until Jul 7, 2026)

Other Services-Prepackaged Software companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.